ICUCW | SeaStar Medical Holding Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0250 - 0.0301
52 Week Range	0.0250 - 0.0301
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	28,641
Average Volume	N/A
Shares Outstanding	362,741,912
Market Cap	9,612,661
Sector	Healthcare
Industry	Biotechnology
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	12
Country	USA
Website	ICUCW

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.

ICUCW's peers: ICU, CDIOW, REVBW, OABIW, EFTRW, COEPW, DFLIW, WGSWW

*Chart delayed

Analyzing fundamentals for ICUCW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ICUCW Fundamentals page.

Watching at ICUCW technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ICUCW Technicals page.